Biodesix Inc expected to post a loss of 90 cents a share - Earnings Preview

Biodesix

04/08/2026 24:24

Biodesix Inc BDSX.OQ BDSX.O is expected to  show a rise in quarterly revenue when it reports  results on August 5 for the period ending June 30 2026
The Louisville Colorado-based  company is expected to report a 30.0% increase in revenue to $26.026 million from $20.02 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Biodesix Inc is for a loss of 90 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Biodesix Inc is $28.50, about 29.4% above its last closing price of $22.03
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-1.10
-1.10
-0.81
Beat
26.1
Dec. 31 2026
-0.79
-0.85
-0.49
Beat
42.7
Sep. 30 2025
-1.53
-1.44
-1.16
Beat
19.4​
Jun. 30 2025
-1.36
-1.37
-1.60
Missed
-17.1
​​Mar. 31 2025
-1.26
-1.36
-1.60
Missed
-17.6
Dec. 31 2024
-1.00
-1.33
-1.20
Beat
10​
Sep. 30 2024
-1.46
-1.47
-1.40
Beat
4.5
Jun. 30 2024
-1.84
-1.84
-1.60
Beat
13
This summary was machine generated August 3 at 23:24 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)